drugset / Trial / NCT03518034

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

NCT03518034

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.

Timeline

Start
2018-05-03
Primary completion
2023-01-19
Completion
2023-01-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 40.5 mg Topical